Biosynex S.A.
ALBIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €51 | €48 | €54 | €50 |
| % Growth | 6.3% | -11.5% | 6.7% | – |
| Cost of Goods Sold | €51 | €48 | €64 | €25 |
| Gross Profit | -€0 | -€9 | -€11 | €26 |
| % Margin | -0.6% | -19.8% | -19.7% | 51% |
| R&D Expenses | €0 | €0 | €2 | €1 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €25 | €19 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €1 | €16 | -€2 | €42 |
| Operating Expenses | €1 | €16 | €25 | €63 |
| Operating Income | -€1 | -€10 | -€11 | -€37 |
| % Margin | -1.6% | -21.1% | -20.7% | -74.3% |
| Other Income/Exp. Net | -€50 | €0 | €0 | €18 |
| Pre-Tax Income | -€51 | €0 | €0 | -€20 |
| Tax Expense | -€2 | €1 | €0 | -€2 |
| Net Income | -€49 | -€22 | -€21 | -€18 |
| % Margin | -96.2% | -46.9% | -39.1% | -34.9% |
| EPS | -3.75 | -1.72 | -1.93 | -1.54 |
| % Growth | -118% | 10.9% | -25.3% | – |
| EPS Diluted | -3.75 | -1.72 | -1.93 | -1.54 |
| Weighted Avg Shares Out | 13 | 13 | 11 | 11 |
| Weighted Avg Shares Out Dil | 13 | 13 | 11 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | -€0 |
| Interest Expense | €4 | €5 | €2 | €1 |
| Depreciation & Amortization | €0 | €2 | €17 | €8 |
| EBITDA | -€1 | -€9 | -€1 | -€10 |
| % Margin | -2% | -19.4% | -2.3% | -20.3% |